Teva CEO Schultz: 'Proof Is In The Pudding' For US Biosimilars :: Generics Bulletin
Teva CEO Erez Vigodman Steps Down | CHEManager
Where is Kåre Schultz? | Ctech
Teva CEO Vigodman steps down
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva CEO Erez Vigodman to Step Down - WSJ
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
US Congress grills Teva CEO on Copaxone price hikes - Globes
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva chooses new CEO
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Haaretz.com
A Look At Kare Schultz, The New CEO In Charge Of Teva
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva Appoints Lundbeck's Schultz as CEO | Ctech
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
